{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:27:08Z","timestamp":1784316428172,"version":"3.55.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T00:00:00Z","timestamp":1422316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s12035-014-9086-x","type":"journal-article","created":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T09:08:09Z","timestamp":1422263289000},"page":"1280-1295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Succinobucol, a Lipid-Lowering Drug, Protects Against 3-Nitropropionic Acid-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Cells via Upregulation of Glutathione Levels and Glutamate Cysteine Ligase Activity"],"prefix":"10.1007","volume":"53","author":[{"given":"Dirleise","family":"Colle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan\u00fabia Bonfanti","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Montagna","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Godoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiane F\u00e1tima","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreza Fabro","family":"de Bem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio L.","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,27]]},"reference":[{"key":"9086_CR1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5:40. doi: 10.1186\/1750-1172-5-40","journal-title":"Orphanet J Rare Dis"},{"key":"9086_CR2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1073858410386236","volume":"17","author":"AL Southwell","year":"2011","unstructured":"Southwell AL, Patterson PH (2011) Gene therapy in mouse models of huntington disease. Neuroscientist 17:153\u2013162. doi: 10.1177\/1073858410386236","journal-title":"Neuroscientist"},{"key":"9086_CR3","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD, D\u2019Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 85:5733\u20135737","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9086_CR4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"9086_CR5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00310376","volume":"88","author":"H Heinsen","year":"1994","unstructured":"Heinsen H, Strik M, Bauer M, Luther K, Ulmar G, Gangnus D, Jungkunz G, Eisenmenger W, Gotz M (1994) Cortical and striatal neurone number in Huntington\u2019s disease. Acta Neuropathol 88:320\u2013333","journal-title":"Acta Neuropathol"},{"key":"9086_CR6","first-page":"553","volume":"85","author":"DM Mann","year":"1993","unstructured":"Mann DM, Oliver R, Snowden JS (1993) The topographic distribution of brain atrophy in Huntington\u2019s disease and progressive supranuclear palsy. Acta Neuropathol 85:553\u2013559","journal-title":"Acta Neuropathol"},{"key":"9086_CR7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","volume":"1802","author":"M Damiano","year":"2010","unstructured":"Damiano M, Galvan L, Deglon N, Brouillet E (2010) Mitochondria in Huntington\u2019s disease. Biochim Biophys Acta 1802:52\u201361. doi: 10.1016\/j.bbadis.2009.07.012","journal-title":"Biochim Biophys Acta"},{"key":"9086_CR8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI45691","volume":"121","author":"F Mochel","year":"2011","unstructured":"Mochel F, Haller RG (2011) Energy deficit in Huntington disease: why it matters. J Clin Invest 121:493\u2013499. doi: 10.1172\/JCI45691","journal-title":"J Clin Invest"},{"key":"9086_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2010.06741.x","volume":"114","author":"JM Oliveira","year":"2010","unstructured":"Oliveira JM (2010) Nature and cause of mitochondrial dysfunction in Huntington\u2019s disease: focusing on huntingtin and the striatum. J Neurochem 114:1\u201312. doi: 10.1111\/j.1471-4159.2010.06741.x","journal-title":"J Neurochem"},{"key":"9086_CR10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ilar.48.4.356","volume":"48","author":"S Ramaswamy","year":"2007","unstructured":"Ramaswamy S, McBride JL, Kordower JH (2007) Animal models of Huntington\u2019s disease. ILAR J 48:356\u2013373","journal-title":"ILAR J"},{"key":"9086_CR11","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181\u20134192","journal-title":"J Neurosci"},{"key":"9086_CR12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/molecules15020878","volume":"15","author":"I Tunez","year":"2010","unstructured":"Tunez I, Tasset I, Perez-De La Cruz V, Santamaria A (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington\u2019s disease: past, present and future. Molecules 15:878\u2013916. doi: 10.3390\/molecules15020878","journal-title":"Molecules"},{"key":"9086_CR13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pnpbp.2008.10.013","volume":"33","author":"P Kumar","year":"2009","unstructured":"Kumar P, Kumar A (2009) Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 33:100\u2013108. doi: 10.1016\/j.pnpbp.2008.10.013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9086_CR14","doi-asserted-by":"crossref","first-page":"43245","DOI":"10.1074\/jbc.M305057200","volume":"278","author":"N Bizat","year":"2003","unstructured":"Bizat N, Hermel JM, Humbert S, Jacquard C, Creminon C, Escartin C, Saudou F, Krajewski S, Hantraye P, Brouillet E (2003) In vivo calpain\/caspase cross-talk during 3-nitropropionic acid-induced striatal degeneration: implication of a calpain-mediated cleavage of active caspase-3. J Biol Chem 278:43245\u201343253. doi: 10.1074\/jbc.M305057200","journal-title":"J Biol Chem"},{"key":"9086_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1734-1140(10)70238-3","volume":"62","author":"P Kumar","year":"2010","unstructured":"Kumar P, Kalonia H, Kumar A (2010) Huntington\u2019s disease: pathogenesis to animal models. Pharmacol Rep 62:1\u201314","journal-title":"Pharmacol Rep"},{"key":"9086_CR16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0306-4522(02)00177-X","volume":"113","author":"WT Lee","year":"2002","unstructured":"Lee WT, Itoh T, Pleasure D (2002) Acute and chronic alterations in calcium homeostasis in 3-nitropropionic acid-treated human NT2-N neurons. Neuroscience 113:699\u2013708","journal-title":"Neuroscience"},{"key":"9086_CR17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0306-4522(02)00097-0","volume":"112","author":"WT Lee","year":"2002","unstructured":"Lee WT, Yin HS, Shen YZ (2002) The mechanisms of neuronal death produced by mitochondrial toxin 3-nitropropionic acid: the roles of N-methyl-D-aspartate glutamate receptors and mitochondrial calcium overload. Neuroscience 112:707\u2013716","journal-title":"Neuroscience"},{"key":"9086_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF03167071","volume":"60","author":"P Montilla","year":"2004","unstructured":"Montilla P, Espejo I, Munoz MC, Bujalance I, Munoz-Castaneda JR, Tunez I (2004) Effect of red wine on oxidative stress and hypercholesterolemia induced by feeding a high-cholesterol diet in rat. J Physiol Biochem 60:259\u2013264","journal-title":"J Physiol Biochem"},{"key":"9086_CR19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.brainresbull.2005.09.013","volume":"68","author":"V Perez-De La Cruz","year":"2006","unstructured":"Perez-De La Cruz V, Gonzalez-Cortes C, Pedraza-Chaverri J, Maldonado PD, Andres-Martinez L, Santamaria A (2006) Protective effect of S-allylcysteine on 3-nitropropionic acid-induced lipid peroxidation and mitochondrial dysfunction in rat brain synaptosomes. Brain Res Bull 68:379\u2013383. doi: 10.1016\/j.brainresbull.2005.09.013","journal-title":"Brain Res Bull"},{"key":"9086_CR20","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.neuint.2010.03.008","volume":"56","author":"V Perez-De La Cruz","year":"2010","unstructured":"Perez-De La Cruz V, Elinos-Calderon D, Carrillo-Mora P, Silva-Adaya D, Konigsberg M, Moran J, Ali SF, Chanez-Cardenas ME, Perez-De La Cruz G, Santamaria A (2010) Time-course correlation of early toxic events in three models of striatal damage: modulation by proteases inhibition. Neurochem Int 56:834\u2013842. doi: 10.1016\/j.neuint.2010.03.008","journal-title":"Neurochem Int"},{"key":"9086_CR21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00702-009-0299-5","volume":"117","author":"D Elinos-Calderon","year":"2010","unstructured":"Elinos-Calderon D, Robledo-Arratia Y, Perez-De La Cruz V, Maldonado PD, Galvan-Arzate S, Pedraza-Chaverri J, Santamaria A (2010) Antioxidant strategy to rescue synaptosomes from oxidative damage and energy failure in neurotoxic models in rats: protective role of S-allylcysteine. J Neural Transm 117:35\u201344. doi: 10.1007\/s00702-009-0299-5","journal-title":"J Neural Transm"},{"key":"9086_CR22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2013.04.017","volume":"62","author":"S Ayala-Pena","year":"2013","unstructured":"Ayala-Pena S (2013) Role of oxidative DNA damage in mitochondrial dysfunction and Huntington\u2019s disease pathogenesis. Free Radic Biol Med 62:102\u2013110. doi: 10.1016\/j.freeradbiomed.2013.04.017","journal-title":"Free Radic Biol Med"},{"key":"9086_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2013.03.018","volume":"63","author":"RK Chaturvedi","year":"2013","unstructured":"Chaturvedi RK, Flint Beal M (2013) Mitochondrial diseases of the brain. Free Radic Biol Med 63:1\u201329. doi: 10.1016\/j.freeradbiomed.2013.03.018","journal-title":"Free Radic Biol Med"},{"key":"9086_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40263-013-0124-4","volume":"28","author":"J Liu","year":"2014","unstructured":"Liu J, Wang LN (2014) Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone. CNS Drugs 28:63\u201368. doi: 10.1007\/s40263-013-0124-4","journal-title":"CNS Drugs"},{"issue":"678","key":"9086_CR25","first-page":"e3","volume":"35","author":"C Cusin","year":"2013","unstructured":"Cusin C, Franco FB, Fernandez-Robles C, DuBois CM, Welch CA (2013) Rapid improvement of depression and psychotic symptoms in Huntington\u2019s disease: a retrospective chart review of seven patients treated with electroconvulsive therapy. Gen Hosp Psychiatry 35(678):e3\u2013e5. doi: 10.1016\/j.genhosppsych.2013.01.015","journal-title":"Gen Hosp Psychiatry"},{"key":"9086_CR26","first-page":"371","volume":"55","author":"P Gallina","year":"2011","unstructured":"Gallina P, Paganini M, Lombardini L, Giordano G, Mascalchi M, Romoli AM, Ghelli E, Porfirio B, Vannelli GB, Di Lorenzo N (2011) Progress in restorative neurosurgery: human fetal striatal transplantation in Huntington\u2019s disease. Review. J Neurosurg Sci 55:371\u2013381","journal-title":"J Neurosurg Sci"},{"key":"9086_CR27","doi-asserted-by":"crossref","first-page":"e67658","DOI":"10.1371\/journal.pone.0067658","volume":"8","author":"D Colle","year":"2013","unstructured":"Colle D, Santos DB, Moreira EL, Hartwig JM, dos Santos AA, Zimmermann LT, Hort MA, Farina M (2013) Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats. PLoS One 8:e67658. doi: 10.1371\/journal.pone.0067658","journal-title":"PLoS One"},{"key":"9086_CR28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.brainresbull.2012.01.003","volume":"87","author":"D Colle","year":"2012","unstructured":"Colle D, Hartwig JM, Soares FA, Farina M (2012) Probucol modulates oxidative stress and excitotoxicity in Huntington\u2019s disease models in vitro. Brain Res Bull 87:397\u2013405. doi: 10.1016\/j.brainresbull.2012.01.003","journal-title":"Brain Res Bull"},{"key":"9086_CR29","author":"D Colle","year":"2013","unstructured":"Colle D, Santos DB, Hartwig JM, Godoi M, Braga AL, Farina M (2013) Succinobucol versus probucol: higher efficiency of succinobucol in mitigating 3-NP-induced brain mitochondrial dysfunction and oxidative stress in vitro. Mitochondrion. doi: 10.1016\/j.mito.2013.01.005","journal-title":"Mitochondrion"},{"key":"9086_CR30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2009.04.002","volume":"207","author":"S Yamashita","year":"2009","unstructured":"Yamashita S, Matsuzawa Y (2009) Where are we with probucol: a new life for an old drug? Atherosclerosis 207:16\u201323. doi: 10.1016\/j.atherosclerosis.2009.04.002","journal-title":"Atherosclerosis"},{"key":"9086_CR31","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2165\/00003495-198937060-00002","volume":"37","author":"MM Buckley","year":"1989","unstructured":"Buckley MM, Goa KL, Price AH, Brogden RN (1989) Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia. Drugs 37:761\u2013800","journal-title":"Drugs"},{"key":"9086_CR32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5551\/jat.E610","volume":"15","author":"S Yamashita","year":"2008","unstructured":"Yamashita S, Hbujo H, Arai H, Harada-Shiba M, Matsui S, Fukushima M, Saito Y, Kita T, Matsuzawa Y (2008) Long-term probucol treatment prevents secondary cardiovascular events: a cohort study of patients with heterozygous familial hypercholesterolemia in Japan. J Atheroscler Thromb 15:292\u2013303","journal-title":"J Atheroscler Thromb"},{"key":"9086_CR33","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0002-8703(84)90315-6","volume":"107","author":"KF Browne","year":"1984","unstructured":"Browne KF, Prystowsky EN, Heger JJ, Cerimele BJ, Fineberg N, Zipes DP (1984) Prolongation of the QT interval induced by probucol: demonstration of a method for determining QT interval change induced by a drug. Am Heart J 107:680\u2013684","journal-title":"Am Heart J"},{"key":"9086_CR34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00129784-200202050-00005","volume":"2","author":"JC Tardif","year":"2002","unstructured":"Tardif JC, Gregoire J, L\u2019Allier PL (2002) Prevention of restenosis with antioxidants: mechanisms and implications. Am J Cardiovasc Drugs 2:323\u2013334","journal-title":"Am J Cardiovasc Drugs"},{"key":"9086_CR35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MOL.0b013e32832aee68","volume":"20","author":"R Stocker","year":"2009","unstructured":"Stocker R (2009) Molecular mechanisms underlying the antiatherosclerotic and antidiabetic effects of probucol, succinobucol, and other probucol analogues. Curr Opin Lipidol 20:227\u2013235. doi: 10.1097\/MOL.0b013e32832aee68","journal-title":"Curr Opin Lipidol"},{"key":"9086_CR36","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1124\/jpet.103.059733","volume":"308","author":"C Kunsch","year":"2004","unstructured":"Kunsch C, Luchoomun J, Grey JY, Olliff LK, Saint LB, Arrendale RF, Wasserman MA, Saxena U, Medford RM (2004) Selective inhibition of endothelial and monocyte redox-sensitive genes by AGI-1067: a novel antioxidant and anti-inflammatory agent. J Pharmacol Exp Ther 308:820\u2013829. doi: 10.1124\/jpet.103.059733","journal-title":"J Pharmacol Exp Ther"},{"key":"9086_CR37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.freeradbiomed.2011.11.029","volume":"52","author":"RG Midwinter","year":"2012","unstructured":"Midwinter RG, Maghzal GJ, Dennis JM, Wu BJ, Cai H, Kapralov AA, Belikova NA, Tyurina YY, Dong LF, Khachigian L, Neuzil J, Kagan VE, Stocker R (2012) Succinobucol induces apoptosis in vascular smooth muscle cells. Free Radic Biol Med 52:871\u2013879. doi: 10.1016\/j.freeradbiomed.2011.11.029","journal-title":"Free Radic Biol Med"},{"key":"9086_CR38","unstructured":"Weingarten DM (2004) Process of preparing esters and ethers of probucol and derivatives thereof. Patent WO2004062622"},{"key":"9086_CR39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363","journal-title":"J Immunol Methods"},{"key":"9086_CR40","doi-asserted-by":"crossref","first-page":"29552","DOI":"10.1074\/jbc.M300661200","volume":"278","author":"V Petegnief","year":"2003","unstructured":"Petegnief V, Friguls B, Sanfeliu C, Sunol C, Planas AM (2003) Transforming growth factor-alpha attenuates N-methyl-D-aspartic acid toxicity in cortical cultures by preventing protein synthesis inhibition through an Erk1\/2-dependent mechanism. J Biol Chem 278:29552\u201329559. doi: 10.1074\/jbc.M300661200","journal-title":"J Biol Chem"},{"key":"9086_CR41","first-page":"637","volume":"13","author":"SF Ali","year":"1992","unstructured":"Ali SF, LeBel CP, Bondy SC (1992) Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology 13:637\u2013648","journal-title":"Neurotoxicology"},{"key":"9086_CR42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0009-8981(85)90135-4","volume":"153","author":"JC Fischer","year":"1985","unstructured":"Fischer JC, Ruitenbeek W, Berden JA, Trijbels JM, Veerkamp JH, Stadhouders AM, Sengers RC, Janssen AJ (1985) Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 153:23\u201336","journal-title":"Clin Chim Acta"},{"key":"9086_CR43","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1021\/bi00232a015","volume":"30","author":"M Reers","year":"1991","unstructured":"Reers M, Smith TW, Chen LB (1991) J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 30:4480\u20134486","journal-title":"Biochemistry"},{"key":"9086_CR44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70\u201377","journal-title":"Arch Biochem Biophys"},{"key":"9086_CR45","unstructured":"Cooper AJL (1998) Role of astrocytes in maintaining cerebral glutathione homeostasis and in protecting the brain against xenobiotics and oxidative stress. In: Francis Ta (ed) The role of glutathione in the nervous system, Washington, pp 91\u2013115"},{"key":"9086_CR46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0076-6879(81)77046-0","volume":"77","author":"A Wendel","year":"1981","unstructured":"Wendel A (1981) Glutathione peroxidase. Methods Enzymol 77:325\u2013333","journal-title":"Methods Enzymol"},{"key":"9086_CR47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0076-6879(85)13050-8","volume":"113","author":"GF Seelig","year":"1985","unstructured":"Seelig GF, Meister A (1985) Glutathione biosynthesis; gamma-glutamylcysteine synthetase from rat kidney. Methods Enzymol 113:379\u2013390","journal-title":"Methods Enzymol"},{"key":"9086_CR48","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jpsychires.2013.02.013","volume":"47","author":"D Engel","year":"2013","unstructured":"Engel D, Zomkowski AD, Lieberknecht V, Rodrigues AL, Gabilan NH (2013) Chronic administration of duloxetine and mirtazapine downregulates proapoptotic proteins and upregulates neurotrophin gene expression in the hippocampus and cerebral cortex of mice. J Psychiatr Res 47:802\u2013808. doi: 10.1016\/j.jpsychires.2013.02.013","journal-title":"J Psychiatr Res"},{"key":"9086_CR49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"9086_CR50","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/cdd.2009.22","volume":"16","author":"G Liot","year":"2009","unstructured":"Liot G, Bossy B, Lubitz S, Kushnareva Y, Sejbuk N, Bossy-Wetzel E (2009) Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ 16:899\u2013909. doi: 10.1038\/cdd.2009.22","journal-title":"Cell Death Differ"},{"key":"9086_CR51","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1089\/ars.2010.3586","volume":"15","author":"E Lubos","year":"2011","unstructured":"Lubos E, Loscalzo J, Handy DE (2011) Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 15:1957\u20131997. doi: 10.1089\/ars.2010.3586","journal-title":"Antioxid Redox Signal"},{"key":"9086_CR52","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/BC.2003.059","volume":"384","author":"R Dringen","year":"2003","unstructured":"Dringen R, Hirrlinger J (2003) Glutathione pathways in the brain. Biol Chem 384:505\u2013516. doi: 10.1515\/BC.2003.059","journal-title":"Biol Chem"},{"key":"9086_CR53","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/toxsci\/kfp219","volume":"112","author":"M Farina","year":"2009","unstructured":"Farina M, Campos F, Vendrell I, Berenguer J, Barzi M, Pons S, Sunol C (2009) Probucol increases glutathione peroxidase-1 activity and displays long-lasting protection against methylmercury toxicity in cerebellar granule cells. Toxicol Sci 112:416\u2013426. doi: 10.1093\/toxsci\/kfp219","journal-title":"Toxicol Sci"},{"key":"9086_CR54","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","volume":"1830","author":"SC Lu","year":"2013","unstructured":"Lu SC (2013) Glutathione synthesis. Biochim Biophys Acta 1830:3143\u20133153. doi: 10.1016\/j.bbagen.2012.09.008","journal-title":"Biochim Biophys Acta"},{"key":"9086_CR55","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.freeradbiomed.2013.07.022","volume":"65","author":"T Satoh","year":"2013","unstructured":"Satoh T, McKercher SR, Lipton SA (2013) Nrf2\/ARE-mediated antioxidant actions of pro-electrophilic drugs. Free Radic Biol Med 65:645\u2013657. doi: 10.1016\/j.freeradbiomed.2013.07.022","journal-title":"Free Radic Biol Med"},{"key":"9086_CR56","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.3390\/molecules15107266","volume":"15","author":"KA Jung","year":"2010","unstructured":"Jung KA, Kwak MK (2010) The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 15:7266\u20137291. doi: 10.3390\/molecules15107266","journal-title":"Molecules"},{"key":"9086_CR57","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.bbrc.2004.02.156","volume":"316","author":"Z Cao","year":"2004","unstructured":"Cao Z, Hallur S, Qiu HZ, Peng X, Li Y (2004) Induction of endogenous glutathione by the chemoprotective agent, 3H-1,2-dithiole-3-thione, in human neuroblastoma SH-SY5Y cells affords protection against peroxynitrite-induced cytotoxicity. Biochem Biophys Res Commun 316:1043\u20131049. doi: 10.1016\/j.bbrc.2004.02.156","journal-title":"Biochem Biophys Res Commun"},{"key":"9086_CR58","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1517\/13543780902849244","volume":"18","author":"KM Muldrew","year":"2009","unstructured":"Muldrew KM, Franks AM (2009) Succinobucol: review of the metabolic, antiplatelet and cardiovascular effects. Expert Opin Investig Drugs 18:531\u2013539. doi: 10.1517\/13543780902849244","journal-title":"Expert Opin Investig Drugs"},{"key":"9086_CR59","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.expneurol.2011.11.036","volume":"233","author":"DB Santos","year":"2012","unstructured":"Santos DB, Peres KC, Ribeiro RP, Colle D, dos Santos AA, Moreira EL, Souza DO, Figueiredo CP, Farina M (2012) Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid beta peptide in mice. Exp Neurol 233:767\u2013775. doi: 10.1016\/j.expneurol.2011.11.036","journal-title":"Exp Neurol"},{"key":"9086_CR60","author":"RP Ribeiro","year":"2013","unstructured":"Ribeiro RP, Moreira EL, Santos DB, Colle D, Dos Santos AA, Peres KC, Figueiredo CP, Farina M (2013) Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson\u2019s disease. Neurochem Res. doi: 10.1007\/s11064-012-0965-0","journal-title":"Neurochem Res"},{"key":"9086_CR61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1476-5381.2012.01994.x","volume":"168","author":"ME Solesio","year":"2013","unstructured":"Solesio ME, Saez-Atienzar S, Jordan J, Galindo MF (2013) 3-Nitropropionic acid induces autophagy by forming mitochondrial permeability transition pores rather than activating the mitochondrial fission pathway. Br J Pharmacol 168:63\u201375. doi: 10.1111\/j.1476-5381.2012.01994.x","journal-title":"Br J Pharmacol"},{"key":"9086_CR62","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1523\/JNEUROSCI.6186-08.2009","volume":"29","author":"T Uo","year":"2009","unstructured":"Uo T, Veenstra TD, Morrison RS (2009) Histone deacetylase inhibitors prevent p53-dependent and p53-independent Bax-mediated neuronal apoptosis through two distinct mechanisms. J Neurosci 29:2824\u20132832. doi: 10.1523\/JNEUROSCI. 6186-08.2009","journal-title":"J Neurosci"},{"key":"9086_CR63","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","volume":"45","author":"SJ Tabrizi","year":"1999","unstructured":"Tabrizi SJ, Cleeter MW, Xuereb J, Taanman JW, Cooper JM, Schapira AH (1999) Biochemical abnormalities and excitotoxicity in Huntington\u2019s disease brain. Ann Neurol 45:25\u201332","journal-title":"Ann Neurol"},{"key":"9086_CR64","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neurol.2014.03.005","volume":"170","author":"V Procaccio","year":"2014","unstructured":"Procaccio V, Bris C, Chao de la Barca JM, Oca F, Chevrollier A, Amati-Bonneau P, Bonneau D, Reynier P (2014) Perspectives of drug-based neuroprotection targeting mitochondria. Rev Neurol (Paris) 170:390\u2013400. doi: 10.1016\/j.neurol.2014.03.005","journal-title":"Rev Neurol (Paris)"},{"key":"9086_CR65","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1042\/BJ20040485","volume":"382","author":"AJ Lambert","year":"2004","unstructured":"Lambert AJ, Brand MD (2004) Superoxide production by NADH:ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane. Biochem J 382:511\u2013517. doi: 10.1042\/BJ20040485","journal-title":"Biochem J"},{"key":"9086_CR66","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1089\/ars.2005.7.1140","volume":"7","author":"V Adam-Vizi","year":"2005","unstructured":"Adam-Vizi V (2005) Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal 7:1140\u20131149. doi: 10.1089\/ars.2005.7.1140","journal-title":"Antioxid Redox Signal"},{"key":"9086_CR67","doi-asserted-by":"crossref","first-page":"15612","DOI":"10.1074\/jbc.M414256200","volume":"280","author":"PK Witting","year":"2005","unstructured":"Witting PK, Wu BJ, Raftery M, Southwell-Keely P, Stocker R (2005) Probucol protects against hypochlorite-induced endothelial dysfunction: identification of a novel pathway of probucol oxidation to a biologically active intermediate. J Biol Chem 280:15612\u201315618. doi: 10.1074\/jbc.M414256200","journal-title":"J Biol Chem"},{"key":"9086_CR68","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mam.2008.08.009","volume":"30","author":"CC Franklin","year":"2009","unstructured":"Franklin CC, Backos DS, Mohar I, White CC, Forman HJ, Kavanagh TJ (2009) Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Aspects Med 30:86\u201398. doi: 10.1016\/j.mam.2008.08.009","journal-title":"Mol Aspects Med"},{"key":"9086_CR69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","volume":"30","author":"HJ Forman","year":"2009","unstructured":"Forman HJ, Zhang H, Rinna A (2009) Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med 30:1\u201312. doi: 10.1016\/j.mam.2008.08.006","journal-title":"Mol Aspects Med"},{"key":"9086_CR70","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","volume":"30","author":"SC Lu","year":"2009","unstructured":"Lu SC (2009) Regulation of glutathione synthesis. Mol Aspects Med 30:42\u201359. doi: 10.1016\/j.mam.2008.05.005","journal-title":"Mol Aspects Med"},{"key":"9086_CR71","first-page":"L861","volume":"275","author":"RM Liu","year":"1998","unstructured":"Liu RM, Gao L, Choi J, Forman HJ (1998) Gamma-glutamylcysteine synthetase: mRNA stabilization and independent subunit transcription by 4-hydroxy-2-nonenal. Am J Physiol 275:L861\u2013L869","journal-title":"Am J Physiol"},{"key":"9086_CR72","doi-asserted-by":"crossref","first-page":"21592","DOI":"10.1074\/jbc.M300931200","volume":"278","author":"M McMahon","year":"2003","unstructured":"McMahon M, Itoh K, Yamamoto M, Hayes JD (2003) Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 278:21592\u201321600. doi: 10.1074\/jbc.M300931200","journal-title":"J Biol Chem"},{"key":"9086_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-2797(97)00146-4","volume":"111\u2013112","author":"ME Anderson","year":"1998","unstructured":"Anderson ME (1998) Glutathione: an overview of biosynthesis and modulation. Chem Biol Interact 111\u2013112:1\u201314","journal-title":"Chem Biol Interact"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-9086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-014-9086-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-9086-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T20:37:00Z","timestamp":1717706220000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-014-9086-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,27]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["9086"],"URL":"https:\/\/doi.org\/10.1007\/s12035-014-9086-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,27]]}}}